Literature DB >> 6787526

Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum.

S Komune, S Asakuma, J B Snow.   

Abstract

The electrophysiologic and histopathologic changes in the inner ear caused by the administration of cis-diamminedichloroplatinum (CP) were studied in guinea pigs. The endocochlear dc potential (EP) gradually decreased after the intravenous injection of CP and reached approximately 0 mV on the fourth day, but the EP did not become negative. The cochlear microphonics also diminished and could not be recorded on the fourth day. The negative potential of the organ of Corti remained in the normal range during the experiment. A large negative summating potential (SP) was observed one day after injection, but the amplitude of the negative SP became small on the second day. Light microscopic examination demonstrated that the outer hair cells are destroyed in the basal turn of the cochlea and are preserved in the upper turns, while the inner hair cells are almost completely preserved in all turns. The stria vascularis was found to be slightly atrophic. Severe collapse of Reissner's membrane was observed in the basal turn.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787526     DOI: 10.1177/019459988108900226

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  20 in total

1.  [The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy].

Authors:  C-M Schmidt; E Bartholomäus; D Deuster; A Heinecke; A G Dinnesen
Journal:  HNO       Date:  2007-04       Impact factor: 1.284

2.  Meta-Analysis of Distortion Product Otoacoustic Emission Retest Variability for Serial Monitoring of Cochlear Function in Adults.

Authors:  Kelly M Reavis; Garnett P McMillan; Marilyn F Dille; Dawn Konrad-Martin
Journal:  Ear Hear       Date:  2015 Sep-Oct       Impact factor: 3.570

3.  Distortion-product otoacoustic emission test performance for ototoxicity monitoring.

Authors:  Kelly M Reavis; Garnett McMillan; Donald Austin; Frederick Gallun; Stephen A Fausti; Jane S Gordon; Wendy J Helt; Dawn Konrad-Martin
Journal:  Ear Hear       Date:  2011-02       Impact factor: 3.570

4.  Is intratympanic injection of erdosteine protective against cisplatin-induced ototoxicity?

Authors:  Issam Saliba; Fouad El Fata
Journal:  Neurotox Res       Date:  2011-10-12       Impact factor: 3.911

5.  Evaluation of audiometric threshold shift criteria for ototoxicity monitoring.

Authors:  Dawn Konrad-Martin; Kenneth E James; Jane S Gordon; Kelly M Reavis; David S Phillips; Gene W Bratt; Stephen A Fausti
Journal:  J Am Acad Audiol       Date:  2010-05       Impact factor: 1.664

6.  Changes in the stria vascularis of the guinea pig due to cis-platinum.

Authors:  R A Tange; V D Vuzevski
Journal:  Arch Otorhinolaryngol       Date:  1984

7.  Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model.

Authors:  P Giordano; G Lorito; A Ciorba; A Martini; S Hatzopoulos
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-08       Impact factor: 2.124

8.  High-frequency click-evoked otoacoustic emissions and behavioral thresholds in humans.

Authors:  Shawn S Goodman; Denis F Fitzpatrick; John C Ellison; Walt Jesteadt; Douglas H Keefe
Journal:  J Acoust Soc Am       Date:  2009-02       Impact factor: 1.840

9.  Development of cis-platinum-induced hearing loss in guinea pigs.

Authors:  L J Hoeve; E A Conijn; I R Mertens zur Borg; M Rodenburg
Journal:  Arch Otorhinolaryngol       Date:  1987

10.  Cis-platinum ototoxicity after radiation treatment: an animal model.

Authors:  C C Baranak; R F Wetmore; R J Packer
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.